Brief: Coloplast Sees 2024/25 EBIT Margin Before Special Items Of 27-28%

Coloplast A/S

06/05/2025 07:24

May 6 (Reuters) - Coloplast A/S COLOb.CO:

OUTLOOK FY ORGANIC GROWTH 7%

Q2 EBIT MARGIN 27%

Q2 EBIT DKK 1,807 MILLION

Q2 REVENUE DKK 6,930 MILLION VERSUS. ESTIMATE DKK 7,025 MILLION

Q2 ADJUSTED EBIT DKK 1,891 MILLION VERSUS. ESTIMATE DKK 1,940 MILLION

Q2 PRETAX PROFIT DKK 1,491 MILLION

Q2 NET INCOME DKK 912 MILLION

OUTLOOK 24/25: EBIT MARGIN BEFORE SPECIAL ITEMS OF 27-28%

OUTLOOK 24/25: ORGANIC GROWTH AROUND 7% IN CONSTANT CURRENCIES, FROM PREVIOUSLY 8-9%

OUTLOOK 24/25: REPORTED GROWTH IN DKK AROUND 4%, FROM PREVIOUSLY AROUND 7%

SPECIAL ITEMS FY 24/25 NOW EXPECTED TO BE AROUND DKK 450 MILLION

DO NOT EXPECT MATERIAL FINANCIAL IMPACT FROM TARIFFS IN FY 2024/25

ASSUMING EXEMPTIONS FOR CHRONIC CARE PRODUCTS REMAIN IN PLACE, FINANCIAL IMPACT FROM US TARIFFS BEYOND THIS FINANCIAL YEAR EXPECTED TO BE IMMATERIAL

Source text: ID:nGNE6V9yJS

Further company coverage: [COLOb.CO]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))